05:48 PM EST, 11/10/2025 (MT Newswires) -- Patrick Burnett, Executive Vice President and Chief Medical Officer, on November 06, 2025, sold 17,250 shares in Arcutis Biotherapeutics ( ARQT ) for $417,145. Following the Form 4 filing with the SEC, Burnett has control over a total of 98,325 common shares of the company, with 98,325 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1787306/000174198725000008/xslF345X05/wk-form4_1762814517.xml